France· FR:65077051
INVANZ 1 g, poudre pour solution à diluer pour perfusion
A ertapenem product containing ertapénem sodique, registered in France by MERCK SHARP & DOHME (PAYS-BAS). The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Ertapenem is registered in 16 of 19 countries.
Countries holding a registration under ATC J01DH03 (ertapenem), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Ertapenem · ATC J01DH03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ertapenem costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ertapenem · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$74.64
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ERTAPÉNEM SODIQUE
- Manufacturer
- MERCK SHARP & DOHME (PAYS-BAS)
- Country
- France (FR)
- ATC code
- J01DH03
- ATC class
- Ertapenem
- Defined daily dose
- 1 g, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009564916501 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for ertapenem.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ertapenem · interactions on record
56 records
- 4 severe
- 13 moderate
- 38 info
Most severe, free to view
- BupropionN06AX12severe
- BupropionN07BA02severe
- IohexolV08AB02severe
- IopamidolV08AB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ertapenem in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsErtapenem Added Pharma 1 g poeder voor concentraat voor oplossing voor infusieAdded Pharma B.V.
- United StatesertapenemWG Critical Care, LLC
- United KingdomErtapenem 1g powder for concentrate for solution for infusion vialsSun Pharma UK Ltd
- SpainERTAPENEM AUROVITAS 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFGEugia Pharma (Malta) Limited
- CzechiaERTAPENEM APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- FinlandErtapenem AptaPharmaApta Medica Internacional d.o.o.
- CanadaERTAPENEM FOR INJECTIONJUNO PHARMACEUTICALS CORP.
- SwedenErtapenem AptaPharma 1 g Pulver till koncentrat till infusionsvätska, lösningAPTA MEDICA INTERNACIONAL
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Bulgaria · Ертапенем Аптафарма
- Cyprus · Ertapenem Aptapharma
- Czechia · Ertapenem Aptapharma, Ertapenem Ash
- Germany · Ertapenem Steriscience
- Denmark · Ertapenem "aptapharma", Ertapenem Fresenius Kabi
- Estonia · Ertapenem Fresenius Kabi, Ertapenem Qilu
- Spain · Ertapenem, Ertapenem Aurovitas
- Finland · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- United Kingdom (Northern Ireland) · Ertapenem Acs Dobfar, Ertapenem Aspire Pharma
- Greece · Ertapenem Anfarm
- Croatia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Hungary · Ertapenem Anfarm, Ertapenem Aptapharma
- Iceland · Invanz
- Italy · Ertapenem Acs Dobfar, Ertapenem Aurobindo
- Liechtenstein · Invanz
- Lithuania · Ertapenem Qilu
- Latvia · Ertapenem Qilu
- Malta · Ertapenem Aptapharma
- Netherlands · Ertapenem Added Pharma, Ertapenem Aptapharma
- Norway · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Poland · Ertapenem Aptapharma, Ertapenem Eugia
- Portugal · Ertapenem, Ertapenem Aurovitas
- Romania · Ertapenem Acs Dobfar, Ertapenem Aptapharma
- Sweden · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Slovenia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
- Slovakia · Ertapenem Aptapharma, Ertapenem Ash
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fcabce57-3986-442c-b343-db552a6340e1 GET /v1/drugs/fcabce57-3986-442c-b343-db552a6340e1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65077051",
"date_amm": "2002-04-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/02/216",
"substance": "ERTAPÉNEM SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ertapenem.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.